Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Publisher Name :
Date: 9-Nov-2012
No. of pages: 221
Inquire Before Buying

GBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations’ (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011.

The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues.

However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies.

Scope

  • Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.
  • API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.
  • API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally.
  • Drivers and restraints for the global APIs market.
  • Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels.
  • Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels.
  • Analysis of API revenues based on therapeutic categories at a global and regional level.

Reasons to buy

  • Develop business strategies with the help with specific insights in the global API market.
  • Identify opportunities and challenges in the global API market.
  • Invest in the growing segments of the APIs market.
  • Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market.
  • Benchmark your operations and strategies against the major players in the global APIs market.

Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Table of Contents

1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 12

2 Introduction 15

3 Global Active Pharmaceutical Ingredients Market 16
3.1 Global API Market Overview 16
3.2 Global API Market Drivers 16
3.2.1 Patent Expiries to Change the Dynamics of the Global API Market 16
3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues 16
3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 16
3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets 16
3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets 17
3.3 Global API Market Restraints 17
3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 17
3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential 17
3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 17
3.3.4 Regulatory Changes to Delay the Launch of New Drugs 18
3.4 Global API Market Revenue Analysis and Forecast to 2017 19
3.4.1 Global API Market Revenue Share by Product Type 21
3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 22
3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 26
3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 27
3.5 Global Biotech Market Analysis 29
3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 29
3.6 Global Biotech Market Revenue Analysis by Customer Base 34
3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 34
3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 35
3.7 Global Contract Manufacturing Organizations 37
3.7.1 Global CMO Outsourcing Process 38
3.7.2 Global CMO Market Drivers 39
3.7.3 Global CMO Market Outsourcing Benefits 40
3.7.4 Global CMO Market Revenues and Forecast to 2017 41

4 North America Active Pharmaceutical Ingredients Market 43
4.1 North America API Market Overview 43
4.2 North America API Market Drivers 43
4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America 43
4.2.2 Generic Sector Supports the Growth of the North American API Market 43
4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 43
4.3 North American API Market Restraints 44
4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 44
4.3.2 High Cost of New Drug Development Hampers Innovation 44
4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 44
4.4 North America API Market Revenue Analysis and Forecast to 2017 45
4.5 North America API Market Revenue Share Analysis by Product Type 47
4.6 North America Synthetic Market Analysis 48
4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 48
4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 53
4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 54
4.7 North America Biotech Market Analysis 56
4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56
4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 61
4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 62
4.8 North America API Market Revenue Share Analysis by Therapeutic Applications 64
4.9 The US Active Pharmaceutical Ingredients Market 65
4.9.1 The US API Market Overview 65
4.9.2 The US API Market Revenue by Product Type and Forecast to 2017 66
4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 68
4.9.4 The US API Market by Customer Base 69
4.10 Canada Active Pharmaceutical Ingredients Market 75
4.10.1 Canada API Market Overview 75
4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 75
4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 77
4.10.4 Canada API Market by Customer Base 78

5 Asia-Pacific Active Pharmaceutical Ingredients Market 84
5.1 Asia-Pacific API Market Overview 84
5.2 Asia-Pacific APIs Market Drivers 85
5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture 85
5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth 85
5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth 85
5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs 85
5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 85
5.3 Asia-Pacific API Market Restraints 86
5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 86
5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 86
5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 86
5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region 86
5.4 Asia-Pacific API Market Revenue and Forecasts to 2017 87
5.5 Asia-Pacific Revenue Share Analysis by Product Type 89
5.6 Asia-Pacific Synthetic Market 90
5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 90
5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 95
5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 96
5.7 Asia-Pacific Biotech Market 98
5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 98
5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104
5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 105
5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 107
5.9 Japan Active Pharmaceutical Ingredients Market 108
5.9.1 Japan API Market Overview 108
5.9.2 Japan API Market Revenues and Forecasts to 2017 108
5.9.3 Japan API Market Revenue Share Analysis by Product Type 110
5.9.4 Japan API Market by Customer Base 111
5.10 China Active Pharmaceutical Ingredients Market 117
5.10.1 China API Market Overview 117
5.10.2 China API Market Revenues by Product Type and Forecasts to 2017 118
5.10.3 China API Market Revenue Share Analysis by Product Types 120
5.10.4 China API Market by Customer Base 121
5.11 South Korea Active Pharmaceutical Ingredients Market 127
5.11.1 South Korea API Market Overview 127
5.11.2 South Korea APIs Market Revenue and Forecasts to 2017 128
5.11.3 South Korea API Market Revenue Share Analysis by Product Type 130
5.11.4 South Korea API Market by Customer Base 131
5.12 India Active Pharmaceutical Ingredients Market 137
5.12.1 India API Market Overview 137
5.12.2 India API Market Revenue and Forecasts to 2017 138
5.12.3 India API Market Revenue Share Analysis by Product Types 140
5.12.4 India API Market by Customer Base 141

6 Europe Active Pharmaceutical Ingredients Market 147
6.1 Europe API Market Overview 147
6.2 Europe API Market Drivers 147
6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe 147
6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market 147
6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 147
6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 147
6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 147
6.3 Europe API Market Restraints 148
6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products 148
6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 148
6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 149
6.4 Europe API Market Revenue Analysis and Forecast to 2017 151
6.5 Europe API Market Revenue Share Analysis by Product Type 153
6.6 Europe Synthetic Market Analysis 154
6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 154
6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159
6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 160
6.7 Europe Biotech Market Analysis 162
6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 162
6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 167
6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 168
6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 170
6.9 Germany Active Pharmaceutical Ingredients Market 172
6.9.1 Germany API Market Overview 172
6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 172
6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 174
6.9.4 Germany API Market by Customer Base 175
6.10 France Active Pharmaceutical Ingredients Market 181
6.10.1 France API Market Overview 181
6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 181
6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 183
6.10.4 France API Market by Customer Base 184
6.11 Italy Active Pharmaceutical Ingredients Market 190
6.11.1 Italy API Market Overview 190
6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 190
6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 192
6.11.4 Italy API Market by Customer Base 193
6.12 The UK Active Pharmaceutical Ingredients Market 199
6.12.1 The UK API Market Overview 199
6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 199
6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 201
6.12.4 The UK API Market by Customer Base 202
6.13 Spain Active Pharmaceutical Ingredients Market 208
6.13.1 Spain API Market Overview 208
6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 208
6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 210
6.13.4 Spain API Market by Customer Base 211

7 Appendix 217
7.1 Abbreviations 217
7.2 Bibliography 218
7.3 Market Definitions 219
7.4 Methodology 219
7.4.1 Coverage 219
7.4.2 Secondary Research 220
7.4.3 Primary Research 220
7.4.4 Expert Panel Validation 220
7.5 Contact Us 221
7.6 Disclaimer 221

List of Tables

Table 1: API Market, Global, Total Revenue Analysis, $m, 2005-2017 20
Table 2: API Market, Global, Revenue Share by Product Types, %, 2011 21
Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005-2017 23
Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011 24
Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005-2017 25
Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011 26
Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017 28
Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005-2017 30
Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011 31
Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005-2017 33
Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011 34
Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017 36
Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011 39
Table 14: CMO Market, Global, Market Revenues, $m, 2005-2017 42
Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012-2016 44
Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005-2017 46
Table 17: API Market, North America, Revenue Share by Product Type, %, 2005-2017 47
Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005-2017 49
Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011 50
Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005-2017 52
Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011 53
Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017 55
Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005-2017 57
Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011 58
Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005-2017 60
Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011 61
Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017 63
Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011-2017 65
Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005-2017 67
Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005-2017 68
Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017 70
Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005-2017 71
Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017 73
Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005-2017 74
Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005-2017 76
Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005-2017 77
Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017 79
Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005-2017 80
Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017 82
Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005-2017 83
Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005-2017 88
Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 89
Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005-2017 91
Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 92
Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005-2017 95
Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 95
Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005-2017 97
Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005-2017 99
Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 100
Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017 103
Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011 104
Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005-2017 106
Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011-2017 107
Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005-2017 109
Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005-2017 110
Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 112
Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005-2017 113
Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 115
Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005-2017 116
Table 60: API Market, China, Market Revenues by Product Type, $m, 2005-2017 119
Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005-2017 120
Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005-2017 122
Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017 123
Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005-2017 125
Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017 126
Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005-2017 129
Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005-2017 130
Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 132
Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017 133
Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 135
Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017 136
Table 72: API Market, India, Market Revenues by Product Types, $m, 2005-2017 139
Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005-2017 140
Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005-2017 142
Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017 143
Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005-2017 145
Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017 146
Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011 149
Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005-2017 152
Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011 153
Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005-2017 155
Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011 156
Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005-2017 158
Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011 159
Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017 161
Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005-2017 163
Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011 164
Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005-2017 166
Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011 167
Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017 169
Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011-2017 171
Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005-2017 173
Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005-2017 174
Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017 176
Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005-2017 177
Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017 179
Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005-2017 180
Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005-2017 182
Table 99: API Market, France, Revenue Share by Product Type, %, 2005-2017 183
Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005-2017 185
Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005-2017 186
Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005-2017 188
Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005-2017 189
Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005-2017 191
Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005-2017 192
Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017 194
Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005-2017 195
Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017 197
Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005-2017 198
Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005-2017 200
Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005-2017 201
Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017 203
Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005-2017 204
Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017 206
Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005-2017 207
Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005-2017 209
Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005-2017 210
Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017 212
Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005-2017 213
Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017 215
Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005-2017 216

List of Figures

Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005-2017 19
Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011 21
Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005-2017 22
Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011 24
Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005-2017 25
Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011 26
Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017 27
Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005-2017 29
Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011 31
Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005-2017 32
Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011 34
Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017 35
Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project 38
Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011 39
Figure 15: CMO Market Key Benefits of Outsourcing to CMOs 40
Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017 41
Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005-2017 45
Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005-2017 47
Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005-2017 48
Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011 50
Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005-2017 51
Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005-2017 52
Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53
Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017 54
Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005-2017 56
Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011 58
Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005-2017 59
Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005-2017 60
Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011 61
Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017 62
Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011-2017 64
Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005-2017 66
Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005-2017 68
Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005-2017 69
Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005-2017 71
Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005-2017 72
Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005-2017 74
Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005-2017 75
Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005-2017 77
Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017 78
Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005-2017 80
Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017 81
Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005-2017 83
Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005-2017 87
Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011 89
Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005-2017 90
Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 92
Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017 93
Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005-2017 94
Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 95
Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005-2017 96
Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005-2017 98
Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 100
Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017 101
Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005-2017 102
Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011 104
Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005-2017 105
Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011-2017 107
Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005-2017 108
Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005-2017 110
Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 111
Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005-2017 113
Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 114
Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005-2017 116
Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005-2017 118
Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005-2017 120
Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005-2017 121
Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017 123
Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005-2017 124
Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017 126
Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005-2017 128
Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005-2017 130
Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 131
Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017 133
Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 134
Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017 136
Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005-2017 138
Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005-2017 140
Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005-2017 141
Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017 143
Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005-2017 144
Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017 146
Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005-2017 151
Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011 153
Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005-2017 154
Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011 156
Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017 157
Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005-2017 158
Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011 159
Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005-2017 160
Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005-2017 162
Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011 164
Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017 165
Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005-2017 166
Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011 167
Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005-2017 168
Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011-2017 170
Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005-2017 172
Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005-2017 174
Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017 175
Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005-2017 177
Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017 178
Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005-2017 180
Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005-2017 181
Figure 105: API Market, France, Revenue Share by Product Type (%), 2005-2017 183
Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005-2017 184
Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005-2017 186
Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005-2017 187
Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005-2017 189
Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005-2017 190
Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005-2017 192
Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017 193
Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005-2017 195
Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017 196
Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005-2017 198
Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005-2017 199
Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005-2017 201
Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017 202
Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005-2017 204
Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017 205
Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005-2017 207
Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005-2017 208
Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005-2017 210
Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017 211
Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005-2017 213
Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017 214
Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005-2017 216

  • Chinese Vacuum Pumps Industry to Grow at a CAGR of 5.5% to 2018
    A vacuum pump is used in most of the activities we do in our every day life. Some of its regular application are air conditioning, automobiles, CDs andDVDs, television tubes, etc. It is also used in hi-tech companies for creating process like coating of microchips and also manufacturing of optical glass or analytical instruments. The [...]
  • Overcoming Obesity
    In today’s world where there are countries struggling to overcome famine and shortage of food there are others who are increasingly getting populated with obese people. Obesity is one of the key problem many are facing across the world. It is a result of either improper lifestyle and food habits or is completely hereditary. In [...]
  • The Booming Market of Carbon Fibre
    The speed at which the Carbon Fibre Industry is growing it is sure to be one of the most profitable industry in the years to come. The sales of carbon fibre tow is expected to increase from $1.6 billion in 2011 to $4.5 billion in 2020. The overall The global demand for carbon fibre tow [...]
  • Incentivising Research & Development Activities
    Research and Development (R&D) is the base of innovation, competitiveness and economic performance. Any company or a country that seeks to be ahead of its competitors need to invest heavily in setting up an active R&D wing. In today’s world everything is technology oriented.  People are coming up with new ideas, products and newer ways [...]
  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • The Boom In Women Infertility Market
  • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Retaining the Hard-Won Consumers
  • With the increase in mobile phone usage different operators are coming up with different plan in order to cater to users of all age-group with various data plan to choose from. With the maturing mobile market operators are coming up …

  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Portable Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
    Published: 27-Mar-2015        Price: US $4000 Onwards        Pages: 659
    WinterGreen Research announces that it has published a new study Portable Oxygen Concentrators: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. The 2015 study has 458 pages, 150 tables and figures. Worldwide markets are poised to achieve continuing growth. Portable oxygen concentrators support lifestyle for oxygen users. Portable oxygen concentrators are approved by the FAA for use on airlines. People on oxygen wish to continue usual activities. Distributors are concentrated ......
  • China Human Vaccine Industry Report, 2015-2018
    Published: 27-Mar-2015        Price: US $2500 Onwards        Pages: 138
    A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to suspected deaths stemming from vaccination and some companies’ (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) production halts of some products because of their failure to pass new GMP certification, China’s human vaccine lot release volume in 2014 declined by 2.4% year on year......
  • Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) – Global Forecast to 2019
    Published: 26-Mar-2015        Price: US $4650 Onwards        Pages: 210
    The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. The growth of the global ......
  • Tumor Ablation Market by Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis) – Global Forecasts to 2019
    Published: 26-Mar-2015        Price: US $4650 Onwards        Pages: 195
    The global tumor ablation market is poised to grow at a CAGR of 11.5% during 2014-2019, and is expected to reach a value of ~462.0 Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period.The growth of the tumor ablation market is driven by factors such as growing geriatric population, coupled with an increasing population base ......
  • Rehabilitation Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
    Published: 26-Mar-2015        Price: US $4000 Onwards        Pages: 659
    WinterGreen Research announces that it has published a new study Rehabilitation Robots:  Market Shares, Strategy, and Forecasts, Worldwide, 2014 to 2020.  The 2015 study has 659 pages, 266 tables and figures.  Worldwide markets are poised to achieve significant growth as the rehabilitation robots, active prostheses, and exoskeletons are used inside rehabilitation treatment centers and sports facilities providing rehabilitation for all patients with injuries or physical dysfunction. Relearn......
  • Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) – Global Forecasts to 2019
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 180
    The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of ~645.0 Million in 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the transplant diagnostics market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period.The growth of the transplant diagnostics market is driven by factors such as growing geriatric population,coupled with an incre......
  • Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography – Global Forecast to 2024
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 200
    The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases. ......
  • Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) – Global Forecasts to 2019
    Published: 25-Mar-2015        Price: US $4650 Onwards        Pages: 210
    The global oncology information system market is estimated to growata CAGR of 8.5% from 2014 to 2019. Although mature markets such as the U.S., the U.K., and Germany hold larger shares in the oncology information system market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 11.5% in the next five years.Factors such as increasing government initiatives for modernization of healthcare infrastructure, growing patient population, and rising focus of international and domest......
  • Global Foley Catheters Market 2015-2019
    Published: 25-Mar-2015        Price: US $3000 Onwards        Pages: 106
    What is Foley Catheter? A Foley catheter, also called an indwelling catheter, is inserted into the bladder to drain urine. It comprises a balloon that holds the catheter in the bladder at one end.  The balloon is filled with sterile water to prevent the catheter from being removed from the bladder. The urine is drained through the catheter tube into a collection bag. Foley catheters are used for extended periods of time, such as for weeks or a month.  These catheters are used after urologic......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs